It’s no secret that artificial intelligence and virtual technologies are quickly changing the patient experience. Today, provider organizations are grappling with questions about the best ways to integrate these tools into the practice.
“Historically, we focused on human innovations in healthcare to really drive patient experience, but we are now not only focusing on human factors like...
A study published in Nature has demonstrated how artificial intelligence (AI) research can drive and accelerate new scientific discoveries.
Alphabet subsidiary DeepMind has created a dedicated, interdisciplinary team to explore using AI to predict the 3D structure of a protein based solely on its genetic sequence.
Its system, AlphaFold, builds on prior research using large genomic datasets to...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
About the author: Anish Sebastian co-founded Babyscripts in 2013, which has partnered with dozens of health systems for its data-centric model in prenatal care. As the CEO of the startup, Anish has focused his efforts on product and software development, as well as evidence-based validation of their product. Prior to this, he founded a research analytics startup and served as a senior tech...
Google’s artificial intelligence proved more accurate in identifying breast cancer from mammograms than doctors, according to a study published in Nature yesterday.
The initial results of Google’s AI for breast cancer screening, found that the system was able to reduce the number of both false positives and false negatives in breast cancer detection. The study was born out of a collaboration...
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures.
WHAT THEY DO
OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
Nines, a tele-radiology and artificial intelligence startup, unveiled its software platform alongside news of a $16.5 million Series A raise. The funding was led by Accel and 8VC, with individual participants also taking part.
WHAT THEY DO
The two-year-old startup’s efforts are broken into two camps. On the one hand is a tele-radiology service that’s staffed by live specialists, and according to...
Ada Health is expanding its services in East Africa with a new Swahili language version of its artificial intelligence assessment app.
The tool is pitched as a way for clinicians and patients to get more information about potential symptom causes as well as localized action steps about what to do next.
“The Swahili version of the Ada app can be accessed via smartphone, and offers support to...
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding.
Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million.
WHAT THEY DO
PathAI’s platform employs convolutional neural...
